49 related articles for article (PubMed ID: 15379988)
1. Assessment of autoimmunity-inducing potential using the brown Norway rat challenge model.
White KL; David DW; Butterworth LF; Klykken PC
Toxicol Lett; 2000 Mar; 112-113():443-51. PubMed ID: 10720764
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species in the initiation of IL-4 driven autoimmunity as a potential therapeutic target.
Wu Z; MacPhee IA; Oliveira DB
Curr Pharm Des; 2004; 10(8):899-913. PubMed ID: 15032693
[TBL] [Abstract][Full Text] [Related]
3. Resistance to re-challenge in the Brown Norway rat model of vasculitis is not always complete and may reveal separate effector and regulatory populations.
Vinen CS; Turner DR; Oliveira DB
Immunology; 2004 Oct; 113(2):269-76. PubMed ID: 15379988
[TBL] [Abstract][Full Text] [Related]
4. A role for alphabeta T cells in the resistant phase of the Brown Norway rat model of vasculitis.
Vinen CS; Turner DR; Oliveira DB
Clin Exp Immunol; 2005 Apr; 140(1):32-40. PubMed ID: 15762872
[TBL] [Abstract][Full Text] [Related]
5. A central role for the mast cell in early phase vasculitis in the Brown Norway rat model of vasculitis: a histological study.
Vinen CS; Turner DR; Oliveira DB
Int J Exp Pathol; 2004 Jun; 85(3):165-74. PubMed ID: 15255970
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A exacerbates mercuric chloride-induced vasculitis in the brown Norway rat.
Qasim FJ; Mathieson PW; Thiru S; Oliveira DB
Lab Invest; 1995 Feb; 72(2):183-90. PubMed ID: 7853852
[TBL] [Abstract][Full Text] [Related]
7. Oxpentifylline inhibits tumor necrosis factor-alpha mRNA transcription and protects against arthritis in mercuric chloride-treated brown Norway rats.
Kiely PD; Gillespie KM; Oliveira DB
Eur J Immunol; 1995 Oct; 25(10):2899-906. PubMed ID: 7589090
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD8 treatment reduces the severity of inflammatory arthritis, but not vasculitis, in mercuric chloride-induced autoimmunity.
Kiely PD; O'Brien D; Oliveira DB
Clin Exp Immunol; 1996 Nov; 106(2):280-5. PubMed ID: 8918574
[TBL] [Abstract][Full Text] [Related]
9. Neonatal induction of tolerance to T(h)2-mediated autoimmunity in rats.
Field AC; Caccavelli L; Fillion J; Kuhn J; Mandet C; Druet P; Bellon B
Int Immunol; 2000 Oct; 12(10):1467-77. PubMed ID: 11007765
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunity and tolerance: relevance to vaccine development.
Czerkinsky C; Anjuere F; McGhee JR; George-Chandy A; Holmgren J; Kieny MP; Fujiyashi K; Mestecky JF; Pierrefite-Carle V; Rask C; Sun JB
Immunol Rev; 1999 Aug; 170(1):197-222. PubMed ID: 10566152
[TBL] [Abstract][Full Text] [Related]
11. Early vasculitis in the mercuric chloride induced Brown Norway rat model is neutrophil independent.
Harris FE; Turner DR; Oliveira DB
Int J Exp Pathol; 1999 Jun; 80(3):133-42. PubMed ID: 10469269
[TBL] [Abstract][Full Text] [Related]
12. Low-dose mercuric chloride induces resistance in brown norway rats to further mercuric chloride by up-regulation of interferon-gamma.
Szeto C; Gillespie KM; Mathieson PW
Scand J Immunol; 1999 Aug; 50(2):195-201. PubMed ID: 10447925
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte trafficking and regional immunity.
Butcher EC; Williams M; Youngman K; Rott L; Briskin M
Adv Immunol; 1999; 72():209-53. PubMed ID: 10361577
[No Abstract] [Full Text] [Related]
14. Current concepts in mucosal immunity. I. Antigen presentation in the intestine: new rules and regulations.
Mayer L
Am J Physiol; 1998 Jan; 274(1):G7-9. PubMed ID: 9458767
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
